Proudly Supporting

Top Healthcare Systems

Redefining skin closure with silk fibroin.

Buy SYLKE®

2+

Years On The Market

3

Sizes Now Available

5

Peer-Reviewed Studies Published

400K+

Happy SYLKE® Patients

The Final Step, The First Impression

Application & Removal

SYLKE®

Application

SYLKE®

Removal

Why SYLKE®?

Biocompatible

The silk fibroin woven mesh provides biocompatibility, breathability, elasticity, water-resistance, and strength - all in one dressing.

Made Without Cyanoacrylates

Engineered with a medical-grade pressure-sensitive adhesive designed to provide a gentle yet secure approximation, without any cyanoacrylate adhesives.

Zero Drying Time

Our pressure sensitive adhesive does not require drying time.

Water-Resistant

Water-resistant for routine showering when used as directed; avoid soaking or prolonged immersion.

Offloads Tension

Facilitates tension distribution across the incision when paired with subcuticular sutures.

Wear Up To 2 Weeks

Designed to stay in place for up to two weeks.

32cm, 24cm, or 16cm

3 Sizes Now Available

SYLKE® Adhesive Wound Closure
SYLKE® Adhesive Wound Closure
SYLKE® Adhesive Wound Closure

What the clinical evidence is saying.

Follow us on social media and our newsletter to receive info on the latest clinical data.

View Clinical Data

Latest Stories

SYLKE® launches Global Relief: Charitable Use Program

SYLKE® launches Global Relief: Charitable Use Program

Our charitable use program that partners with nonprofits and frontline healthcare teams to deliver SYLKE® Adhesive Wound Closure dressings where they’re needed most.

Read more

SYLKE® is now ISO 13485:2016–certified and MDSAP-audited

SYLKE® is now ISO 13485:2016–certified and MDSAP-audited

SYLKE® Adhesive Wound Closure is now ISO 13485:2016–certified and MDSAP-audited - supporting market access, pending regulatory approval, in the United States, Canada, Australia, Japan, and Brazil.

Read more

$10.03 Million Series A

$10.03 Million Series A

In March 2025, SYLKE® raised a $10.03 million Series A at a $150 million pre-money valuation.

Read more

$5.50 Million Series Seed

$5.50 Million Series Seed

In August 2024, SYLKE® raised a $5.5 million Series Seed at a $50 million pre-money valuation.

Read more